Literature DB >> 10341178

Human rabies postexposure prophylaxis during a raccoon rabies epizootic in New York, 1993 and 1994.

J D Wyatt1, W H Barker, N M Bennett, C A Hanlon.   

Abstract

We describe the epidemiology of human rabies postexposure prophylaxis (PEP) in four upstate New York counties during the 1st and 2nd year of a raccoon rabies epizootic. We obtained data from records of 1,173 persons whose rabies PEP was reported to local health departments in 1993 and 1994. Mean annual PEP incidence rates were highest in rural counties, in summer, and in patients 10 to 14 and 35 to 44 years of age. PEP given after bites was primarily associated with unvaccinated dogs and cats, but most (70%) was not attributable to bites. Although pet vaccination and stray animal control, which target direct exposure, remain the cornerstones of human rabies prevention, the risk for rabies by the nonbite route (e. g., raccoon saliva on pet dogs' and cats' fur) should also be considered.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10341178      PMCID: PMC2640781          DOI: 10.3201/eid0503.990312

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  9 in total

1.  Benefits and costs of using an orally absorbed vaccine to control rabies in raccoons.

Authors:  I J Uhaa; V M Dato; F E Sorhage; J W Beckley; D E Roscoe; R D Gorsky; D B Fishbein
Journal:  J Am Vet Med Assoc       Date:  1992-12-15       Impact factor: 1.936

2.  Rabies surveillance in the United States during 1995.

Authors:  J W Krebs; T W Strine; J S Smith; D L Noah; C E Rupprecht; J E Childs
Journal:  J Am Vet Med Assoc       Date:  1996-12-15       Impact factor: 1.936

3.  Epidemiology of antirabies treatment in Georgia, 1967-71.

Authors:  R W Currier; J E McCroan; D W Dreesen; W G Winkler; R L Parker
Journal:  Public Health Rep       Date:  1975 Sep-Oct       Impact factor: 2.792

4.  Epidemiology of rabies vaccinations of persons in Illinois, 1967-68.

Authors:  R J Martin; P R Schnurrenberger; N J Rose
Journal:  Public Health Rep       Date:  1969-12       Impact factor: 2.792

Review 5.  The ascension of wildlife rabies: a cause for public health concern or intervention?

Authors:  C E Rupprecht; J S Smith; M Fekadu; J E Childs
Journal:  Emerg Infect Dis       Date:  1995 Oct-Dec       Impact factor: 6.883

6.  Raccoon rabies epizootic--United States, 1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1994-04-22       Impact factor: 17.586

7.  The epidemiology of human rabies postexposure prophylaxis, 1980-1981.

Authors:  C G Helmick
Journal:  JAMA       Date:  1983-10-21       Impact factor: 56.272

8.  Human antirabies treatment in the United States, 1972.

Authors:  W G Winkler; K D Kappus
Journal:  Public Health Rep       Date:  1979 Mar-Apr       Impact factor: 2.792

9.  Descriptive epidemiology from an epizootic of raccoon rabies in the Middle Atlantic States, 1982-1983.

Authors:  S R Jenkins; W G Winkler
Journal:  Am J Epidemiol       Date:  1987-09       Impact factor: 4.897

  9 in total
  5 in total

1.  Use of rabies postexposure prophylaxis supplied by the Alaska Section of Epidemiology, Alaska, 2002-2007.

Authors:  Louisa Castrodale
Journal:  Public Health Rep       Date:  2009 Mar-Apr       Impact factor: 2.792

2.  Potential cost savings with terrestrial rabies control.

Authors:  Sergio Recuenco; Bryan Cherry; Millicent Eidson
Journal:  BMC Public Health       Date:  2007-04-02       Impact factor: 3.295

3.  The Economics of a Successful Raccoon Rabies Elimination Program on Long Island, New York.

Authors:  Julie L Elser; Laura L Bigler; Aaron M Anderson; Joanne L Maki; Donald H Lein; Stephanie A Shwiff
Journal:  PLoS Negl Trop Dis       Date:  2016-12-09

4.  Public health impact of reemergence of rabies, New York.

Authors:  Hwa-Gan H Chang; Millicent Eidson; Candace Noonan-Toly; Charles V Trimarchi; Robert Rudd; Barbara J Wallace; Perry F Smith; Dale L Morse
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

5.  Rabies postexposure prophylaxis, New York, 1995-2000.

Authors:  Jesse D Blanton; Nadine Y Bowden; Millicent Eidson; Jeffrey D Wyatt; Cathleen A Hanlon
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.